RET and lung carcinoma: Nevertheless, even if RET antibodies are available, they do not have the sensitivity/specificity to be clinically relevant for the detection of RET fusion proteins, and International Association for the Study of Lung Cancer/College of American Pathologists/Association for Molecular Pathology Guidelines recommend against using IHC to test for RET fusions in patients with lung cancer.58